Novartis Builds On Its Legacy With Scemblix Approval For CML
US FDA approval means a new commercial opportunity in CML, where despite the success of older medicines, patients still fail on therapy.

US FDA approval means a new commercial opportunity in CML, where despite the success of older medicines, patients still fail on therapy.